Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index
Asian Journal of Andrology · 2024
DOI: 10.4103/aja202381 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Asian Journal of Andrology, 2024. Verfasst von Gian Maria Busetto und 18 weiteren Autor:innen. Beteiligte Einrichtung: University of Foggia, Foggia 71122, Italy. Hauptthemen laut MEDLINE: Varicocele, Antioxidants, Body Mass Index, Carnitine. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Oxidative stress is one of the main mechanisms responsible for male infertility. Various conditions such as varicocele, obesity, advanced age, and lifestyle can lead to an increase in reactive oxygen species, causing an oxidative imbalance in the reproductive environment. Spermatozoa are sensitive to reactive oxygen species and require energy to carry out their main function of fertilizing the egg. Excessive reactive oxygen species can affect sperm metabolism, leading to immobility, impaired acrosome reaction, and cell death, thereby impairing reproductive success. This double-blind randomized study evaluated the effect of supplementation with L-carnitine, acetyl-L-carnitine, vitamins, and other nutrients on semen quality in 104 infertile patients with or without varicocele, while also investigating the impact of factors such as obesity and advanced age on treatment. Sperm concentration significantly increased in the supplemented group compared to the placebo group ( P = 0.0186). Total sperm count also significantly increased in the supplemented group ( P = 0.0117), as did sperm motility ( P = 0.0120). The treatment had a positive effect on patients up to 35 years of age in terms of sperm concentration ( P = 0.0352), while a body mass index (BMI) above 25 kg m −2 had a negative effect on sperm concentration ( P = 0.0110). Results were not showing a net benefit in stratifying patients in accordance with their BMI since sperm quality increase was not affected by this parameter. In conclusion, antioxidant supplementation may be beneficial for infertile patients and has a more positive effect on younger patients with a normal weight.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of Foggia, Foggia 71122, Italy.
- Department of Urology and Renal Transplantation, Policlinico of Foggia, Foggia 71122, Italy.
- Department of Urology, Human Reproduction Section, Federal University of Sao Paulo, Sao Paulo 05403-000, Brazil.
- Alfasigma Healthscience, Utrecht 3528 BG, The Netherlands.
- Urology Unit, "G. Tatarella" Hospital, Cerignola 71042, Italy.
- Urology Unit, European Institute of Oncology (IEO) IRCCS, Milan 20142, Italy.
Zitieren
APA
Busetto, G. M., Rodrigues, B. F., Virmani, A., Checchia, A., Ninivaggi, A., Ricapito, A., Barbieri, G., Fischetti, P., Falagario, U. G., Annese, P., d'Altilia, N., Mancini, V., Ferro, M., Crocetto, F., Porreca, A., Bettocchi, C., Cormio, L., Agarwal, A., & Carrieri, G. (2024). Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index. Asian Journal of Andrology. https://doi.org/10.4103/aja202381
Vancouver
Busetto GM, Rodrigues BF, Virmani A, Checchia A, Ninivaggi A, Ricapito A, et al. Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index. Asian Journal of Andrology. 2024. doi:10.4103/aja202381
BibTeX
@article{Busetto2024,
author = {Busetto, Gian Maria and Rodrigues, Bernarde F and Virmani, Ashraf and Checchia, Andrea and Ninivaggi, Antonella and Ricapito, Anna and Barbieri, Giovanni and Fischetti, Piero and Falagario, Ugo G and Annese, Pasquale and d'Altilia, Nicola and Mancini, Vito and Ferro, Matteo and Crocetto, Felice and Porreca, Angelo and Bettocchi, Carlo and Cormio, Luigi and Agarwal, Ashok and Carrieri, Giuseppe},
title = {Antioxidant treatment for oligoasthenoteratozoospermia and varicocele: a DBPC trial to evaluate the impact of age and body mass index},
journal = {Asian Journal of Andrology},
year = {2024},
doi = {10.4103/aja202381}
}
EUVIMED